| 000 | 01441 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513100449.0 | ||
| 264 | 0 | _c19970124 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0952-3278 | ||
| 024 | 7 |
_a10.1016/s0952-3278(96)90057-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSolomon, H | |
| 245 | 0 | 0 |
_aThe effect of prostanoids on hepatic bile flow in dogs with normal liver and bile duct cell hyperplasia. _h[electronic resource] |
| 260 |
_bProstaglandins, leukotrienes, and essential fatty acids _cApr 1996 |
||
| 300 |
_a265-71 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _a1-Naphthylisothiocyanate |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBile _xdrug effects |
| 650 | 0 | 4 |
_aBile Acids and Salts _xblood |
| 650 | 0 | 4 |
_aBile Duct Diseases _xchemically induced |
| 650 | 0 | 4 |
_aCholestasis _xmetabolism |
| 650 | 0 | 4 |
_aCommon Bile Duct _xpathology |
| 650 | 0 | 4 |
_aDinoprostone _xpharmacology |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEpoprostenol _xpharmacology |
| 650 | 0 | 4 |
_aGlucagon _xpharmacology |
| 650 | 0 | 4 | _aHyperplasia |
| 650 | 0 | 4 |
_aSecretin _xpharmacology |
| 700 | 1 | _aContis, J | |
| 700 | 1 | _aLi, A P | |
| 700 | 1 | _aKaminski, D L | |
| 773 | 0 |
_tProstaglandins, leukotrienes, and essential fatty acids _gvol. 54 _gno. 4 _gp. 265-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0952-3278(96)90057-5 _zAvailable from publisher's website |
| 999 |
_c8798963 _d8798963 |
||